Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 87

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 87
---
 have previously
filed with the SEC, except in each case the information contained in such document to the extent “furnished” and not “filed”:

| ● 
 ● | Our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, filed with the SEC on December 14, 2022, as amended by Form 10-K/A filed with the SEC on January 27, 2023.                                                                                                            
 Our Quarterly Reports on Form 10-Q for the quarterly periods ended December 31, 2022 and March 31, 2023, filed with the SEC on February 9, 2023 and May 11, 2023, respectively.                                                                                                                    |
|:--|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ● | Our Current Reports on Form 8-K filed with the SEC on February 28, 2023, March 28, 2023, and May 5, 2023.                                                                                                                                                                                          |
| ● | The description of our capital stock contained in our registration statement on Form 8-A (File No. 001-36745) filed with the Commission on November 13, 2014, pursuant to Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description. |

We also incorporate by reference all documents we file in the future
pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus and prior to the sale of all the securities
covered by this prospectus (including all such documents filed with the SEC after the date of the initial filing of the Registration Statement
that contains this prospectus and prior to effectiveness of the Registration Statement or after such effectiveness), except in each case
the information contained in such document to the extent “furnished” and not “filed.”

You may obtain copies of these documents on the website maintained
by the SEC at , or from us without charge (other than exhibits to such documents, unless such exhibits are specifically
incorporated by reference into such documents) by writing us at Corporate Secretary, Applied DNA Sciences, Inc., 50 Health Sciences Drive,
Stony Brook, New York 11790 or visiting our website at .

Any statement contained in a document incorporated or deemed to be
incorporated by reference in this prospectus shall be deemed to be modified or superseded for the purposes of this prospectus